FDA label e00a5656-4e00-4eeb-80df-03ff947b46b7

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
2c51acbc-033b-40a2-93b1-81ba89223b13
SPL ID
e00a5656-4e00-4eeb-80df-03ff947b46b7
Version
2
Effective date
2017-06-23
Source export date
2026-08-01
Source partition
13
Source file
https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-08-01/63703fa640102c69d41ceeb8d73f46d0a0be448587814b2aeca60b43bed7e054/drug-label-0013-of-0014.json.zip
Source manifest SHA-256
bdd1454d0606b622b70458a306b8a10d8a8787db06fd9f46e69c7f7a4524b630
Import run
20260801T225920Z
Imported at
2026-08-01 23:36:39

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning Withdraw plunger of syringe to make sure the needle point is not in a blood vessel.

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

Adverse Reactions Patient should be maintained in a recumbent position for 10 to 15 minutes following injection. A local sensation is to be expected, limited to the distribution of the nerve injected, and usually appearing as a temporary feeling of heaviness, although some cases will feel heat or a transitory aggravation of symptoms.